Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 10  •  04:00PM ET
73.18
Dollar change
+0.27
Percentage change
0.37
%
Index
NDX, S&P 500
P/E
16.07
EPS (ttm)
4.55
Insider Own
0.29%
Shs Outstand
455.74M
Perf Week
4.02%
Market Cap
33.39B
Forward P/E
13.11
EPS next Y
5.58
Insider Trans
0.00%
Shs Float
454.95M
Perf Month
0.73%
Enterprise Value
39.56B
PEG
1.25
EPS next Q
1.05
Inst Own
89.18%
Perf Quarter
-16.99%
Income
2.08B
P/S
1.62
EPS this Y
10.14%
Inst Trans
5.81%
Perf Half Y
-2.60%
Sales
20.62B
P/B
3.21
EPS next Y
10.44%
ROA
5.96%
Perf YTD
-10.78%
Book/sh
22.77
P/C
7.40
EPS next 5Y
10.49%
ROE
22.15%
52W High
89.77 -18.48%
Perf Year
17.50%
Cash/sh
9.89
P/FCF
22.19
EPS past 3/5Y
2.53% 0.61%
ROIC
10.32%
52W Low
59.70 22.59%
Perf 3Y
-9.19%
EV/EBITDA
11.40
Sales past 3/5Y
3.99% 3.74%
Gross Margin
39.70%
Volatility
2.27% 2.50%
Perf 5Y
-
EV/Sales
1.92
EPS Y/Y TTM
4.69%
Oper. Margin
14.03%
ATR (14)
2.20
Perf 10Y
-
Quick Ratio
1.08
Sales Y/Y TTM
4.85%
Profit Margin
10.11%
RSI (14)
50.51
Current Ratio
1.33
EPS Q/Q
-17.95%
SMA20
2.82%
Beta
1.29
Debt/Eq
1.01
Sales Q/Q
7.13%
SMA50
-4.07%
Rel Volume
0.73
Prev Close
72.91
Employees
54000
LT Debt/Eq
0.95
SMA200
-4.77%
Avg Volume
3.68M
Price
73.18
IPO
Dec 15, 2022
Option/Short
Yes / Yes
Trades
Volume
2,691,408
Change
0.37%
Date Action Analyst Rating Change Price Target Change
Jan-15-26Downgrade UBS Neutral → Sell $77
Oct-13-25Initiated Barclays Equal Weight $86
Oct-07-25Downgrade Citigroup Buy → Neutral $83
May-05-25Upgrade UBS Sell → Neutral $73
Mar-11-25Upgrade Goldman Neutral → Buy $85 → $100
Jan-08-25Upgrade Jefferies Hold → Buy $95 → $103
Sep-26-24Downgrade UBS Neutral → Sell $84 → $74
Sep-18-24Upgrade BTIG Research Neutral → Buy $100
Sep-09-24Initiated JP Morgan Neutral $90
Aug-06-24Initiated Stifel Buy $100
Apr-06-26 07:00AM
Mar-31-26 04:10PM
Mar-27-26 09:30AM
Mar-26-26 08:30AM
Mar-25-26 09:00AM
07:51AM Loading…
Mar-24-26 07:51AM
06:00AM
Mar-23-26 09:59AM
Mar-18-26 04:00PM
Mar-17-26 09:00AM
Mar-12-26 04:51PM
Mar-11-26 05:45AM
05:26AM
Mar-10-26 01:39PM
01:11PM
09:00AM Loading…
Mar-09-26 09:00AM
Mar-05-26 09:33AM
09:00AM
Mar-04-26 12:30PM
10:50AM
12:38AM
Mar-03-26 12:19PM
10:15AM
09:50AM
Mar-02-26 08:31AM
Feb-28-26 11:57AM
Feb-27-26 11:07PM
12:45PM
12:37PM
11:40AM
11:46AM Loading…
Feb-26-26 11:46AM
11:14AM
Feb-25-26 12:51PM
12:49PM
11:57AM
09:40AM
Feb-24-26 12:15PM
09:40AM
Feb-23-26 11:44PM
03:43PM
07:21AM
Feb-20-26 04:58PM
01:02PM
12:22PM
11:44AM
09:04AM
07:29AM
Feb-19-26 09:00AM
08:04AM
07:56AM
Feb-18-26 01:09PM
10:53AM
09:51AM
09:48AM
02:32AM
Feb-17-26 03:32PM
11:20AM
11:12AM
09:00AM
Feb-16-26 11:32AM
10:52AM
09:42AM
Feb-15-26 06:53AM
Feb-12-26 06:11PM
12:57PM
11:03AM
07:30AM
Feb-11-26 11:40AM
12:36AM
Feb-10-26 12:20PM
Feb-09-26 12:06PM
10:40AM
08:00AM
Feb-06-26 08:53AM
07:05AM
Feb-05-26 12:44PM
09:00AM
12:35AM
Feb-04-26 04:26PM
04:02PM
01:38PM
01:20PM
11:03AM
10:12AM
10:10AM
09:42AM
09:30AM
07:30AM
07:03AM
07:01AM
06:46AM
06:36AM
06:35AM
06:20AM
Feb-03-26 01:13PM
11:31AM
Feb-02-26 10:11PM
09:40AM
09:15AM
08:29AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
Kenneth StacherskiFormer OfficerOct 27 '25Proposed Sale78.954,585361,993Oct 27 04:26 PM
Kenneth StacherskiFormer OfficerSep 22 '25Proposed Sale74.4619,5241,453,773Sep 22 04:44 PM
Kenneth StacherskiFormer OfficerSep 12 '25Proposed Sale77.0311,757905,590Sep 12 04:47 PM
Rott RolandCEO, ImagingSep 11 '25Option Exercise55.915,341298,59232,128Sep 12 04:05 PM